Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (2019 - 2025)

Benitec Biopharma has reported Shares Outstanding over the past 7 years, most recently at $34.3 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $34.3 million for Q4 2025, up 46.07% from a year ago — trailing twelve months through Dec 2025 was $34.3 million (up 46.07% YoY), and the annual figure for FY2025 was $26.3 million, up 160.26%.
  • Shares Outstanding reached $34.3 million in Q4 2025 per BNTC's latest filing, up from $26.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $34.3 million in Q4 2025 and bottomed at $480688.0 in Q2 2021.
  • Median Shares Outstanding over the past 5 years was $6.5 million (2021), compared with a mean of $10.4 million.
  • The largest annual shift saw Shares Outstanding plummeted 81.42% in 2022 before it surged 837.55% in 2025.
  • Over 5 years, Shares Outstanding stood at $8.2 million in 2021, then tumbled by 79.86% to $1.6 million in 2022, then soared by 57.5% to $2.6 million in 2023, then skyrocketed by 804.61% to $23.5 million in 2024, then soared by 46.07% to $34.3 million in 2025.
  • Business Quant data shows Shares Outstanding for BNTC at $34.3 million in Q4 2025, $26.3 million in Q3 2025, and $26.3 million in Q2 2025.